政策利好推动指数止跌！跨年行情来临，还有哪些投资机会？

Group 1 - The A-share market is expected to benefit from upward liquidity trends, with valuations currently at a relatively reasonable level compared to global equity markets, remaining at a medium to low level [1] - By 2026, earnings are anticipated to become the focal point for the market, with the improvement of listed companies' fundamentals driven by China's economic transformation and the development of emerging industries [1] - The narrowing decline in PPI is expected to support a further recovery in corporate profit margins, while attention should be paid to potential disruptions from the US midterm elections, geopolitical risks, and the pace of domestic economic recovery [1] Group 2 - The pharmaceutical sector has seen a slowdown in its upward momentum after a strong rally earlier in the year, with a significant reduction in the number of "doubling funds" [3] - As of November 28, only two pharmaceutical-themed funds maintained year-to-date doubling returns, indicating a shift in market sentiment from aggressive accumulation to cautious observation [3] - Despite the current transitional phase characterized by clear policy bottoms and visible valuation bottoms, the long-term growth logic of the pharmaceutical industry remains intact, supported by ongoing policy reinforcement and improvements in cash flow [3] Group 3 - Lithium battery production is expected to increase month-on-month in December, with a strong demand leading to price increases across multiple segments [5] - Sample companies reported a battery production of 143.3 GWh, a month-on-month increase of 2.3%, marking the first month-on-month increase in battery production since 2022 [5] - The tightening supply and strong demand in the energy storage sector are anticipated to lead to improved profitability across the lithium battery supply chain [5] Group 4 - The short-term trend of the market is strong, with significant inflows of incremental capital and a strong profit-making effect [7] - The Shanghai Composite Index's rebound is seen as a positive stimulus from insurance capital, although the actual implementation of beneficial policies is still pending [11] - The market is expected to maintain a slow bull trend, with potential for further liquidity easing and a focus on sectors such as new energy equipment, industrial machinery, computing power, and high-end manufacturing [11]